The Swiss Agency for Therapeutic Products, Swissmedic, has authorised a third vaccine against swine flu A/H1N1.
The product is called Celtura and is made by the Swiss pharmaceutical group, Novartis, which is based in Basel.
In a statement on Friday, the federal authorities said that unlike vaccines already authorised in October - Focetria and Pandemrix – the antigen components of Celtura were not based on hens' eggs but on a cell culture.
They said that on the basis of clinical data available, Celtura had been permitted for children above the age of three and for adults of all age groups.
But the data had shown that for adults over the age of 40, sufficient immunisation was only reached after a second vaccination of the drug. This had to be done three weeks after the first.
Swissmedic said it had not received any further applications for the authorisation of vaccines against swine flu.
All rights reserved. The content of the website by swissinfo.ch is copyrighted. It is intended for private use only. Any other use of the website content beyond the use stipulated above, particularly the distribution, modification, transmission, storage and copying requires prior written consent of swissinfo.ch. Should you be interested in any such use of the website content, please contact us via contact@swissinfo.ch.
As regards the use for private purposes, it is only permitted to use a hyperlink to specific content, and to place it on your own website or a website of third parties. The swissinfo.ch website content may only be embedded in an ad-free environment without any modifications. Specifically applying to all software, folders, data and their content provided for download by the swissinfo.ch website, a basic, non-exclusive and non-transferable license is granted that is restricted to the one-time downloading and saving of said data on private devices. All other rights remain the property of swissinfo.ch. In particular, any sale or commercial use of these data is prohibited.
Talking business
in depth
Curious Switzerland
Price comparison
in depth
in depth
'Together'
in depth